Trial intelligence / Profile preview

Effect of different doses of esketamine on vagal reflex during cord polyp extraction

ChiCTR2400087440Phase 4Not yet recruiting

Sponsor
The Second Xiangya Hospital
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in laryngeal polyp (3 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: heart rate and mean arterial pressure. Planned start Jul 2024; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

laryngeal polyp

Beyond the preview

Go deeper on ChiCTR2400087440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400087440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call